jcp conference-coverage

Conference Coverage

Changes in PROs Can Predict Treatment Response and Survival in Metastatic Gastrointestinal Cancer

10/04/2021

Results from a study presented at the 2021 ASCO Quality Care Symposium showed that 1-month changes in patient-reported outcomes predicted treatment responses and survival outcomes among patients with metastatic GI cancer.

Results from a study presented...

10/04/2021

Journal of Clinical Pathways

Conference Coverage

Platform Identifies Discrepancies Between Practice Guidelines and Real-World Practice Patterns in MM

07/22/2021

An analysis of patient data using an online patient portal suggests a disparity exists between practice recommendations and real-world practice patterns for patients with MM.

An analysis of patient data...

07/22/2021

Journal of Clinical Pathways

Conference Coverage

Cost-Effectiveness of Perioperative Chemotherapy vs Adjuvant Chemoradiation for Gastric Cancer

07/20/2021

A recent study comparing perioperative chemotherapy with adjuvant chemoradiotherapy among patients with gastric cancer suggests that perioperative chemotherapy may be more cost-effective.

A recent study comparing...

07/20/2021

Journal of Clinical Pathways

Conference Coverage

Cardiac Risk Factors and Adverse Events Among Patients With CLL Treated in Real-World Setting

07/15/2021

Real-world study findings reveal higher cardiovascular adverse event rates among patients with CLL receiving ibrutinib monotherapy, when compared to those receiving intensive therapy.

Real-world study findings reveal...

07/15/2021

Journal of Clinical Pathways

Conference Coverage

Toxicity Costs Among Patients With Melanoma Receiving Ipilimumab and Nivolumab

07/14/2021

Study findings show the cost of toxicities among patients with metastatic melanoma receiving ipilimumab and nivolumab were small, encompassing 3% of total costs.

Study findings show the cost of...

07/14/2021

Journal of Clinical Pathways

Conference Coverage

Real-World PFS Among Patients With Ovarian Cancer Receiving First-Line Maintenance Therapy vs Active Surveillance

07/14/2021

Though most patients with ovarian cancer do not receive first-line maintenance therapy, those who do may be more likely to experience improved PFS.

Though most patients with...

07/14/2021

Journal of Clinical Pathways

Conference Coverage

US Budget Impact of Rituximab-abbs vs Subcutaneous Rituximab for CLL and NHL

07/14/2021

A budget impact model estimated that intravenous rituximab-abbs may yield significant annual cost savings compared to subcutaneous rituximab for patients with NHL and CLL.

A budget impact model estimated...

07/14/2021

Journal of Clinical Pathways

Conference Coverage

Real-world Safety and Efficacy of Bendamustine Plus Rituximab for Indolent NHL or MCL

07/13/2021

Study results show bendamustine plus rituximab is feasible for patients with NHL or MCL in the real-world setting.

Study results show bendamustine...

07/13/2021

Journal of Clinical Pathways

Conference Coverage

Real-World Daratumumab Response Across Lines of Therapy for Patients With MM

07/12/2021

A recent real-world study suggests that daratumumab-based regimens are an effective treatment option for MM across all lines of therapy, presenting the strongest response in the first-line setting.

A recent real-world study...

07/12/2021

Journal of Clinical Pathways

Conference Coverage

Budget Impact Analysis of Body Surface Area vs Flat-Fixed Rituximab Dosing for NHL and CLL

07/08/2021

Study findings suggest there may be economic benefit in replacing a proportion of flat-fixed rituximab/hyaluronidase human subcutaneous injection use with body surface area-based rituximab-abbs for patients with NHL and CLL from a US payer...

Study findings suggest there may...

07/08/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products